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background:  Blood pressures response to antihypertensives regimens varies among different ethnicities. Black patients are at greater risk for 
treatment resistant hypertension than white patients, the incidence and prevalence of cardiovascular and renal complications of hypertension 
are greater than in other race/ethnicity groups. Catheter-based renal denervation (RDN) had shown to be an effective treatment to control blood 
pressure (BP) in patients with resistant hypertension. However, in the Symplicity HTA- 1 and 2 trials more than 95% of the population was Caucasian. 
Therefore, the efficacy of this novel procedure in other race/ethnicity groups is still unknown.
Methods:  Prospective, multicenter, observational registry of consecutive patients submitted to RDN at 20 centers in Venezuela between 
February and December 2012. We included patients with resistant hypertension defined as systolic BP > 160 mmHg despite taking three or more 
antihypertensive drugs. Patients were divided in 2 groups Caucasian (group 1) and non-Caucasians (group 2). The objective was to compare BP 
reduction at 1-month follow-up between the groups.
results:  Ninety-seven patients were included in this analysis. Mean age was 54.9 ± 11; 46% were females and 33% were diabetics with no 
significant difference between the groups. Pre-procedure systolic BP was 173 ± 98 mmHg in group 1 and 176 ± 102 mmHg in group 2 (p=0.6) with 
a mean number of anti-hypertensive medications of 4.3 vs. 4.2 (p=0.9). Regarding the procedural characteristics the number of radiofrequency 
applications per patient was similar with 10.0 ± 1.8 in group 1 vs. 9.9 ± 1.8 in group 2 (p = 0.8). At 30 days follow-up BP decreased 32/13 mmHg 
in group 1 and 33/17 mm Hg in group 2 (p = 0.8).
conclusions:  In this comparative analysis RDN was equally effective reducing systolic BP in different race/ethnicity groups.
